Welcome to LookChem.com Sign In|Join Free
  • or
N-ME-D-PHG-OH, also known as N-methyl-D-phenylglycine, is a chemical compound with the molecular formula C9H11NO2. It is a derivative of the amino acid phenylglycine, and the N-methylated form has been of interest for its potential pharmacological properties. N-ME-D-PHG-OH has been studied for its potential use as a precursor in the synthesis of pharmaceuticals and as a building block in organic chemistry. Additionally, it has been investigated for its potential biological activity, including its role as an antihypertensive agent. While further research is needed to fully understand its properties and potential applications, N-ME-D-PHG-OH shows promise in various fields of chemistry and pharmacology.

30925-14-5

Post Buying Request

30925-14-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

30925-14-5 Usage

Uses

Used in Pharmaceutical Synthesis:
N-ME-D-PHG-OH is used as a precursor in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with improved therapeutic properties.
Used in Organic Chemistry:
N-ME-D-PHG-OH is used as a building block in organic chemistry for its ability to form new compounds and contribute to the advancement of chemical research.
Used in Antihypertensive Applications:
N-ME-D-PHG-OH is used as an antihypertensive agent for its potential role in lowering blood pressure and managing hypertension, although further research is needed to confirm its efficacy and safety in this application.
Used in Research and Development:
N-ME-D-PHG-OH is used in research and development for its potential biological activity and pharmacological properties, with ongoing studies aimed at understanding its full potential and exploring new applications in various fields of chemistry and pharmacology.

Check Digit Verification of cas no

The CAS Registry Mumber 30925-14-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,9,2 and 5 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 30925-14:
(7*3)+(6*0)+(5*9)+(4*2)+(3*5)+(2*1)+(1*4)=95
95 % 10 = 5
So 30925-14-5 is a valid CAS Registry Number.

30925-14-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-(-)-α-methylamino phenylacetic acid

1.2 Other means of identification

Product number -
Other names N-ALPHA-METHYL-D-PHENYLGLYCINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:30925-14-5 SDS

30925-14-5Relevant academic research and scientific papers

Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium

Al-Awadhi, Fatma H.,Ratnayake, Ranjala,Paul, Valerie J.,Luesch, Hendrik

, p. 3276 - 3282 (2016/07/21)

In search of novel protease inhibitors with therapeutic potential, our efforts exploring the marine cyanobacterium Lyngbya sp. have led to the discovery of tasiamide F (1), which is an analogue of tasiamide B (2). The structure was elucidated using a combination of NMR spectroscopy and mass spectrometry. The key structural feature in 1 is the presence of the Phe-derived statine core, which contributes to its aspartic protease inhibitory activity. The antiproteolytic activity of 1 and 2 was evaluated in vitro against cathepsins D and E, and BACE1. Tasiamide F (1) displayed IC50values of 57?nM, 23?nM, and 0.69?μM, respectively, indicating greater selectivity for cathepsins over BACE1 compared with tasiamide B (2). Molecular docking experiments were carried out for compounds 1 and 2 against cathepsins D and E to rationalize their activity towards these proteases. The dysregulated activities of cathepsins D and E have been implicated in cancer and modulation of immune responses, respectively, and these proteases represent potential therapeutic targets.

Synthesis of optically active α-methylamino acids and amides through biocatalytic kinetic resolution of amides

Wang, Mei-Xiang,Liu, Jun,Wang, De-Xian,Zheng, Qi-Yu

, p. 2409 - 2416 (2007/10/03)

Catalyzed by Rhodococcus sp. AJ270, a nitrile hydratase and amidase containing microbial whole-cell catalyst, under very mild conditions, a number of racemic α-methylamino amides were resolved into the corresponding optically active (S)-(+)-α-methylamino acids and (R)-(-)-α- methylamino amides. The steric requirement of the amidase against α-amino phenylacetamides bearing methyl group(s) at α-amino nitrogen and/or α-carbon was also studied. Coupled with the chemical hydrolysis of amide, the biotransformation process provided a direct synthesis of α-methylamino acids in both enantiomeric forms from readily available racemic amides.

Optical Resolution and Asymmetric Transformation of (RS)-N-Alkyl- and (RS)-N,N-Dialkyl-2-phenylglycines

Shiraiwa, Tadashi,Baba, Yoshihisa,Miyazaki, Hideya,Sakata, Shinji,Kawamura, Seiko,et al.

, p. 1430 - 1437 (2007/10/02)

Optical resolution of (RS)-N-methyl-2-phenylglycine and (RS)-N-ethyl-2-phenylglycine was carried out by using (1S)-10-camphorsulfonic acid as resolving agents, and that of (RS)-N-ethyl-N-methyl-2-phenylglycine by (R)- and (S)-1-phenylethylamine.Racemization rates of optically active Mpg, Epg, Emp, N,N-dimethyl-2-phenylglycine , and six α-amino acids were measured by heating in carboxylic acids.The electron-donating amino acid side chain and N-substituted alkyl group decreased therate to inhibit the formation of intermediary carbanions, whereas the electron-withdrawing side chain increased it.Asymmetric transformation of (RS)-Mpg, (RS)-Epg, and (RS)-Dmp was carried out on the basis of the results of optical resolution and racemization to give the corresponding enantiomers of approximately 100percent optical purities in over 70percent yield based on the sterting racemates.

NITROGEN ALKYLATION OF SCHIFF BASES AND AMIDINES AS A ROUTE TO N-ALKYL AMINO ACIDS

O'Donnell, Martin J.,Bruder, William A.,Daugherty, Byron W.,Liu, Deshan,Wojciechowski, Krzisztof

, p. 3651 - 3654 (2007/10/02)

Schiff base and amidine esters 3 are alkylated and then hydrolyzed to yield N-alkyl amino acids 4 in 41-75percent yield with hight to complete retention of optical activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 30925-14-5